Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company. It is engaged in developing treatments that address both the regional and systemic nature of a patient’s cancer. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its lead product candidate, INT230-6, comprises three components: cisplatin, a proven anti-cancer cytotoxic agent, vinblastine sulfate, also a proven anti-cancer cytotoxic agent, and an amphiphilic molecule (SHAO) which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection. Its pipeline consists of INVINCIBLE-3 Study, a Phase 3 open-label, randomized study testing the superiority INT230-6 used as monotherapy compared to the standard of care drugs in 2nd and 3rd line treatment for certain soft tissue sarcoma subtypes, a Phase 2 clinical study in metastatic triple negative breast cancer.
Find out what a historical investment in Intensity Therapeutics Inc would be worth today using our INTS stock calculator.
Buying INTS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Intensity Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in INTS
What is the ticker symbol of Intensity Therapeutics Inc?
The ticker symbol for Intensity Therapeutics Inc is INTS.
How much is one share of INTS?
One share of INTS is valued at $2.50 as of 20 November 2026.
What is the market capitalisation of Intensity Therapeutics Inc INTS?
As of 20 November 2026 Intensity Therapeutics Inc has a market cap of $8.72M.
What is the 52-week high for Intensity Therapeutics Inc stock?
The Intensity Therapeutics Inc 52-week high stock price is $15.00.
What is the 52-week low for Intensity Therapeutics Inc stock?
The Intensity Therapeutics Inc 52-week low stock price is $2.50.
Can I buy INTS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy INTS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in INTS on Stake
Buy INTS from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of INTS from only US$10 with fractional shares